Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-N-methyl-D-glucamine

Details for Australian Patent Application No. 2006235486 (hide)

Owner Panacos Pharmaceuticals, Inc.

Inventors Hausherr, Arndt; O'Neil, Michael H.; Walker, Randall M.; Martin, David E.; Sweetapple, Gary G.; Koch, Gunter

Agent Houlihan2

Pub. Number AU-A-2006235486

PCT Pub. Number WO2006/110810

Priority 60/670,227 12.04.05 US

Filing date 12 April 2006

Wipo publication date 19 October 2006

International Classifications

A61K 31/704 (2006.01)

C07J 17/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/110810 Priority application(s): WO2006/110810

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235487-Nanoparticulate quinazoline derivative formulations

2006235483-Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection